Estimates compiled by Modular Finance on behalf of Ambea.
Number of contributors: 5 (all of which have been updated or confirmed before the report)
| Ambea, Group (MSEK, unless otherwise specified) | Q3 2026E |
| Net sales | 4,379 |
| Organic growth (%) | 4.70 |
| Adjusted EBITA | 617 |
| Profit before tax | 414 |
| Earnings per share (SEK) | 4.13 |
| Net sales per segment | |
| Nytida | 1,200 |
| Vardaga | 1,449 |
| Stendi | 917 |
| Validia | 455 |
| Altiden | 345 |
| Klara | 84.5 |
| Group adjustments | - 48.7 |
| Adjusted EBITA incl. IFRS 16 per segment | |
| Nytida | 206 |
| Vardaga | 192 |
| Stendi | 114 |
| Validia | 66.9 |
| Altiden | 41.1 |
| Klara | 8.65 |
| Unallocated items | - 8.58 |
More consensus estimates can be found on Ambea’s webpage: https://ambea.com/investor-relations/the-share/consensus/
Ambea’s Q3 report will be released on Wednesday 4 November at 7:00 CET.